- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
IDH1-R132 changes vary according to NPM1 and other mutations status in AML ; day:8 ; month:1 ; year:2019 ; pages:1-5
Leukemia ; (8.1.2019), 1-5
- Creator
-
Falini, Brunangelo
Spinelli, Orietta
Meggendorfer, Manja
Martelli, Maria Paola
Bigerna, Barbara
Ascani, Stefano
Stein, Harald
Rambaldi, Alessandro
Haferlach, Torsten
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-018-0299-2
- URN
-
urn:nbn:de:101:1-2019021123394600548760
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Falini, Brunangelo
- Spinelli, Orietta
- Meggendorfer, Manja
- Martelli, Maria Paola
- Bigerna, Barbara
- Ascani, Stefano
- Stein, Harald
- Rambaldi, Alessandro
- Haferlach, Torsten
- SpringerLink (Online service)
Other Objects (12)
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
Significance of targeting DNMT3A mutations in AML
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Deciphering Effects of Idh1-R132H Mutations on the Regulation of Hematopoietic Differentiation
Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
Significance of targeting DNMT3A mutations in AML
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Deciphering Effects of Idh1-R132H Mutations on the Regulation of Hematopoietic Differentiation
Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
Significance of targeting DNMT3A mutations in AML
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Deciphering Effects of Idh1-R132H Mutations on the Regulation of Hematopoietic Differentiation
Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas